Publicidad
Publicidad

Más contenido relacionado

Publicidad

treatment of mitochondrial diseases.pptx

  1. Treatmentand preventionof mitochondrial Reporter:XXX
  2. As with all mitochondrial diseases, there is no cure. Mitochondrial diseases tend to affect multiple organ systems. The cells and organs most severely adfected are those most heavily dependent on ATP ( brain ,muscle ,nerve ,heart ,
  3. Pancrease , eye , ear ,kidney ,gastrointestinal system
  4. ENTER YOUR TITLE Click here to add content of the text,and briefly explain your point of view. ENTER YOUR TITLE Click here to add content of the text,and briefly explain your point of view. ENTER YOUR TITLE Click here to add content of the text,and briefly explain your point of view. ENTER YOUR TITLE Click here to add content of the text,and briefly explain your point of view. ENTER YOUR TITLE Click here to add content of the text,and briefly explain your point of view.
  5. Treatment varies from patient to patient and depends on the specific mitochondrial disease diagnosed and its severity. However, there's no way to predict a patient’s response to treatment or predict how the disease will affect that person in the long run. No two people will respond to the same treatment in the same way, even if they have the same disease.
  6. Kearns-Sayre Syndrome (KSS) Coenzyme Q10, insulin for diabetes, cardiac drugs, and a cardiac pacemaker which may be life- saving. Surgical intervention for drooping eyelids may be considered but should be undertaken by specialists in ophthalmic surgical centers. FOR
  7. Pearson syndrome Red blood cell transfusions are often needed to manage the macrocytic anemia, and patients may be dependent on transfusions. Erythropoietin has been tried to decrease the frequency of transfusions. Pancreatic enzyme replacement is needed for patients FOR
  8. with malabsorption due to exocrine pancreatic insufficiency. Supplementation with fat-soluble vitamins may also be needed. . In neutropenic patients, fever higher than 101.5° F should be evaluated promptly. Parenteral antibiotics should be administered after blood is obtained. Splenic atrophy may also increase the risk of bacteremia due to encapsulated organism. Granulocyte colony- stimulating factor (G-CSF) has been used in some patients to ameliorate severe neutropenia.
  9. MELAS SYNDROME Moderate treadmill training can help improve the endurance of individuals with myopathy. Metabolic therapies, including dietary supplements, have shown benefits for some individuals. These treatments include coenzyme Q10, phylloquinone, menadione, ascorbate, riboflavin, nicotinamide, creatine monohydrate, idebenone, succinate, and dichloroacetate. FOR
  10. Myoclonic epilepsy with ragged- red fibers (MERRF) Therapies may include coenzyme Q10, L- carnitine, and various vitamins, often in a "cocktail" combination. Management of seizures usually requires anticonvulsant drugs. Medications for control of other symptoms may also be necessary. FOR
  11. Myoclonic epilepsy with ragged- red fibers (MERRF) Therapies may include coenzyme Q10, L- carnitine, and various vitamins, often in a "cocktail" combination. Management of seizures usually requires anticonvulsant drugs. Medications for control of other symptoms may also be necessary. FOR
  12. Leber hereditary optic neuropathy(LHON) Management of affected individuals is supportive and includes provision of visual aids and registration with the relevant social services. ECG may reveal a pre-excitation syndrome in both affected and unaffected LHON carriers; such a finding does not necessitate further intervention in the absence of cardiac symptoms. FOR
Publicidad